94 related articles for article (PubMed ID: 8179718)
21. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
22. Autocrine factor enhancing the secretion of M(r) 95,000 gelatinase (matrix metalloproteinase 9) in serum-free medium conditioned with murine metastatic colon carcinoma cells.
Hyuga S; Nishikawa Y; Sakata K; Tanaka H; Yamagata S; Sugita K; Saga S; Matsuyama M; Shimizu S
Cancer Res; 1994 Jul; 54(13):3611-6. PubMed ID: 8012988
[TBL] [Abstract][Full Text] [Related]
23. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
24. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S; Refolo LM; Sambamurti K
J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
[TBL] [Abstract][Full Text] [Related]
25. A secreted form of human ADAM9 has an alpha-secretase activity for APP.
Hotoda N; Koike H; Sasagawa N; Ishiura S
Biochem Biophys Res Commun; 2002 May; 293(2):800-5. PubMed ID: 12054541
[TBL] [Abstract][Full Text] [Related]
26. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
Ye HQ; Azar DT
Invest Ophthalmol Vis Sci; 1998 May; 39(6):913-21. PubMed ID: 9579471
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
[TBL] [Abstract][Full Text] [Related]
28. The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein.
Allinson TM; Parkin ET; Condon TP; Schwager SL; Sturrock ED; Turner AJ; Hooper NM
Eur J Biochem; 2004 Jun; 271(12):2539-47. PubMed ID: 15182369
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
Sava G; Capozzi I; Bergamo A; Gagliardi R; Cocchietto M; Masiero L; Onisto M; Alessio E; Mestroni G; Garbisa S
Int J Cancer; 1996 Sep; 68(1):60-6. PubMed ID: 8895542
[TBL] [Abstract][Full Text] [Related]
31. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.
Koike H; Tomioka S; Sorimachi H; Saido TC; Maruyama K; Okuyama A; Fujisawa-Sehara A; Ohno S; Suzuki K; Ishiura S
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):371-5. PubMed ID: 10510302
[TBL] [Abstract][Full Text] [Related]
32. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
[TBL] [Abstract][Full Text] [Related]
33. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site.
Hussain I; Powell DJ; Howlett DR; Chapman GA; Gilmour L; Murdock PR; Tew DG; Meek TD; Chapman C; Schneider K; Ratcliffe SJ; Tattersall D; Testa TT; Southan C; Ryan DM; Simmons DL; Walsh FS; Dingwall C; Christie G
Mol Cell Neurosci; 2000 Nov; 16(5):609-19. PubMed ID: 11083922
[TBL] [Abstract][Full Text] [Related]
34. A novel matrix-degrading protease in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Biochem Soc Trans; 1994 Feb; 22(1):49-52. PubMed ID: 8206274
[No Abstract] [Full Text] [Related]
35. The interactions of alpha 2HS glycoprotein with metalloproteinases.
Ochieng J; Green B
Biochem Mol Biol Int; 1996 Sep; 40(1):13-20. PubMed ID: 8886265
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Benbow U; Maitra R; Hamilton JW; Brinckerhoff CE
Ann N Y Acad Sci; 1999 Jun; 878():662-4. PubMed ID: 10415801
[No Abstract] [Full Text] [Related]
37. Matrix metalloproteinases in sterile corneal melts.
Geerling G; Joussen AM; Daniels JT; Mulholland B; Khaw PT; Dart JK
Ann N Y Acad Sci; 1999 Jun; 878():571-4. PubMed ID: 10415776
[No Abstract] [Full Text] [Related]
38. Gelatinases/type IV collagenases in jaw cyst expansion.
Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Sommerhoff CP; Sorsa T
Ann N Y Acad Sci; 1994 Sep; 732():486-8. PubMed ID: 7978847
[No Abstract] [Full Text] [Related]
39. Matrix metalloproteinases.
Roy MK; Carey PD
Br J Surg; 1997 Aug; 84(8):1171. PubMed ID: 9278677
[No Abstract] [Full Text] [Related]
40. Matrix metalloproteinases.
Johnson LL; Dyer R; Hupe DJ
Curr Opin Chem Biol; 1998 Aug; 2(4):466-71. PubMed ID: 9736919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
